According to forecasts, the therapeutic apheresis industry is expected to be US$ 2,717.9 million in 2023 and US$ 5,264.4 million by 2033, the demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The rising prevalence of diseases, increased demand for blood components, and the safety that goes along with …